<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang M</submitter><funding>The National Natural Science Foundation of China</funding><pagination>44</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12911376</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>28(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Dysregulation of N6-methyladenosine (m6A) has been implicated in the pathophysiology of various autoimmune diseases. However, its role in dermatomyositis (DM), particularly in cases associated with anti-MDA5 antibodies, remains unclear. This study aimed to elucidate the potential involvement of m6A modifications of mRNAs in the pathogenesis of anti-MDA5&lt;sup>+&lt;/sup>DM.&lt;h4>Methods&lt;/h4>We assessed mRNA m6A methylation levels in peripheral blood mononuclear cells (PBMCs) from anti-MDA5&lt;sup>+&lt;/sup>DM patients and healthy controls (HC) using LC-MS/MS assay. Quantitative reverse transcription-polymerase chain reaction (RT-qPCR) and Western blotting were conducted to determine the mRNA and protein expression levels of YTHDF2 in PBMCs and monocytes from anti-MDA5&lt;sup>+&lt;/sup>DM pa</pubmed_abstract><journal>Arthritis research &amp; therapy</journal><pubmed_title>Dysregulation of YTHDF2 promotes the over expression of interferon beta in anti-MDA5 antibody-positive dermatomyositis.</pubmed_title><pmcid>PMC12911376</pmcid><funding_grant_id>82572056, 82171788, 82371810</funding_grant_id><pubmed_authors>Geng Q</pubmed_authors><pubmed_authors>Cao X</pubmed_authors><pubmed_authors>Lin S</pubmed_authors><pubmed_authors>Jin Q</pubmed_authors><pubmed_authors>Peng Q</pubmed_authors><pubmed_authors>Zhang M</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Jiao Y</pubmed_authors><pubmed_authors>Xiao C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dysregulation of YTHDF2 promotes the over expression of interferon beta in anti-MDA5 antibody-positive dermatomyositis.</name><description>&lt;h4>Background&lt;/h4>Dysregulation of N6-methyladenosine (m6A) has been implicated in the pathophysiology of various autoimmune diseases. However, its role in dermatomyositis (DM), particularly in cases associated with anti-MDA5 antibodies, remains unclear. This study aimed to elucidate the potential involvement of m6A modifications of mRNAs in the pathogenesis of anti-MDA5&lt;sup>+&lt;/sup>DM.&lt;h4>Methods&lt;/h4>We assessed mRNA m6A methylation levels in peripheral blood mononuclear cells (PBMCs) from anti-MDA5&lt;sup>+&lt;/sup>DM patients and healthy controls (HC) using LC-MS/MS assay. Quantitative reverse transcription-polymerase chain reaction (RT-qPCR) and Western blotting were conducted to determine the mRNA and protein expression levels of YTHDF2 in PBMCs and monocytes from anti-MDA5&lt;sup>+&lt;/sup>DM pa</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-16T00:47:41.59Z</modification><creation>2026-07-09T10:26:31.966Z</creation></dates><accession>S-EPMC12911376</accession><cross_references><pubmed>41580740</pubmed><doi>10.1186/s13075-026-03752-7</doi></cross_references></HashMap>